Article
The prognostic value of CD39+CD8+ T cells as a potential surrogate marker of tumor-specific T cells in Asian triple-negative breast cancer
2023-09-11
Abstract excerpt
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype that is generally associated with poor prognosis in affected patients. Unfortunately, recently approved immune checkpoint inhibitors are efficacious in only a subset of patients. A surrogate marker for tumor-specific CD8 + T cells is urgently required to clarify the mechanisms of antitumor immune responses and help prognosticate TNBC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8f6b1790-a276-504c-846a-8b6cbaa4385e
- DOI
- 10.21203/rs.3.rs-3336490/v1
